Symbols / LABD
LABD Chart
About
The fund, under normal circumstances, invests at least 80% of the fund’s net assets in financial instruments, including swap agreements, futures contracts, or short positions, that, in combination, provide 3X daily inverse (opposite) or short exposure to the index or to ETFs that track the index, consistent with the fund’s investment objective. The index is designed to measure the performance of the biotechnology sub-industry based on the GICS. The fund is non-diversified.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | 7.31% |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | 160.50 | 52W Low | 16.16 |
| Beta | — | Avg Volume | 2.72M | Volume | 1.32M |
| Target Price | — | Recom | — | Prev Close | $16.97 |
| Price | $17.11 | Change | 0.85% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
No analyst ratings or price targets available.
- Understanding Momentum Shifts in (LABD) - Stock Traders Daily hu, 19 Feb 2026 22
- LABD: ETF To Benefit From Downturns In The Biotech Industry (NYSEARCA:LABD) - Seeking Alpha Mon, 02 Feb 2026 08
- FXI, LABD: Big ETF Outflows - Intellectia AI ue, 17 Feb 2026 01
- Avoiding Lag: Real-Time Signals in (LABD) Movement - Stock Traders Daily Sun, 08 Feb 2026 08
- Rocket Lab's Sharp Rebound: What's Behind the Recent Momentum - MarketBeat Fri, 19 Dec 2025 08
- Top Performing Leveraged/Inverse ETFs: 04/06/2025 - ETF Database hu, 10 Apr 2025 07
- Rocket Lab’s Rally Isn’t Random—Big Catalysts Are Ahead - MarketBeat Wed, 07 Jan 2026 08
- Why Astera Labs Stock Is Sinking This Week - Nasdaq Fri, 14 Feb 2025 08
- LABD Stock Fund Price and Chart — AMEX:LABD - TradingView Fri, 21 Jul 2017 01
- Shattuck Labs’ stock craters as biotech scraps main product candidate after failed trial - MarketWatch ue, 01 Oct 2024 07
- Top Performing Leveraged/Inverse ETFs: 11/17/2024 - ETF Trends ue, 19 Nov 2024 08
- How Much US Land Do China and Other Countries Really Own? - Chicago Council on Global Affairs Fri, 29 Mar 2024 07
- How to land an entry-level tech job (Even without experience) - University of Cincinnati ue, 13 May 2025 17
- Amagi Media Labs IPO listing date today. GMP, experts signal debut with a modest premium on Dalal Street - Mint Wed, 21 Jan 2026 08
- Investors Seek Stock Market Crash Protection As Recession Fears Rise - Forbes Wed, 05 Mar 2025 08
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for LABD
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|